MIBG-131I (meta-iodobenzylguanidine) injection for diagnostic use
| Primena | confirmation in suspected neuroectodermally derived tumours including neuroblastoma, phaeochromocytoma and ganglioneuroma, -staging of the disease, follow-up of neuroblastoma under chemotherapy, particularly in stage IV and IVs patients, before and after surgery of the primary tumour, -follow-up after treatment to exclude a sub-clinical relapse, especially in the bone marrow and also in the case of any clinical abnormality during follow- up, particularly bone pain, before planning MIBG therapy |
| Farmaceutski oblik | solution for injection |
| Veličina pakovanja | 10 ml glass vial, closed with rubber stopper and aluminum cap, placed in a lead container. The vial contains a volume of solution corresponding to the activity determined on the calibration day. |
| Sadržaj po bočici | meta-iodobenzylguanidine (131I) activities of 10 – 74 MBq/ml at time of calibration ascorbic acid |
| Karakteristike rastvora | pH 3.5 – 8.0 radionuclidic purity: > 99.9 % radiochemical purity: > 94 % clear, colorless or slightly yellow solution |
| Kalibracija | at the user's request |
| Rok upotrebe | 14 days from the production date (expiry date is stated on the label) |
| Čuvanje | in a refrigerator (2-8 ºC), protect from light |
| Isporuka | na on request |
